Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Antiemetics Companies

ID: MRFR/HC/6982-HCR
110 Pages
Nidhi Mandole
Last Updated: February 16, 2025
Antiemetics are medications designed to prevent or alleviate nausea and vomiting. These drugs are commonly used in various medical conditions, including chemotherapy-induced nausea, postoperative nausea, and motion sickness.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Antiemetics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)4.24%
2024 Market Size$ 37.54 Billion
2025 Market Size$ 39.13 Billion
2035 Market Size$ 59.27 Billion
Key Players
Roche
Novartis
GlaxoSmithKline
Bristol-Myers Squibb
Merck & Co.
Teva Pharmaceutical Industries
Opportunities
  • Growing Geriatric Population
  • Advancements in Drug Development
  • Rising Awareness of Treatment Options

Top Industry Leaders in the Antiemetics Market

Antiemetics Key Companies
 
Latest Antiemetics Companies Update:

Evoke Pharma's Exclusivity: In April 2022, Evoke Pharma received three-year exclusivity for Gimoti (metoclopramide) nasal spray, providing them a competitive edge in the oral alternative drug segment.

Acacia Pharmaceutical's FDA Approval: Barhemsys, Acacia Pharmaceutical's antiemetic, received US-FDA approval in February 2022, expanding their product portfolio and addressing a niche market for nausea and vomiting associated with migraine.

Pfizer's Transdermal Patch Development: In September 2023, Pfizer partnered with Relief Therapeutics to develop a transdermal patch for Aprepitant (Emend), aiming to improve patient compliance and ease of administration for chemotherapy-induced nausea and vomiting.

Meda Pharmaceuticals' Expansion: Meda Pharmaceuticals acquired Australian pharmaceutical company, Almirall, in January 2023, strengthening their market presence in antiemetics with Almirall's innovative NKTR-105.

List of Antiemetics Key companies in the market
  • GSK (UK)
  • Merck (US)
  • Sanofi-Aventis (France)
  • Pfizer Inc. (US)
  • Mylan (US)
  • Eli Lilly and Company (US)
  • Johnson & Johnson (US)
  • Baxter International (US)
  • Reddy's Laboratories Inc. (India)